Cargando…

P1010: PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS HAVE INCREASED NUMBERS OF MYELOID-DERIVED SUPPRESSOR CELLS, AND DECITABINE MAY HAVE A SIGNIFICANT THERAPEUTIC EFFECT IN MPN PATIENTS WITH HIGH MDSCS

Detalles Bibliográficos
Autores principales: Feng, Qiutian, Hu, Shiwei, Xiang, Danhong, Zhang, Xinlu, Zhang, Lan, Wang, Shengjie, Zhu, Xiaoqiong, Huang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431309/
http://dx.doi.org/10.1097/01.HS9.0000970944.20308.82
_version_ 1785091170766946304
author Feng, Qiutian
Hu, Shiwei
Xiang, Danhong
Zhang, Xinlu
Zhang, Lan
Wang, Shengjie
Zhu, Xiaoqiong
Huang, Jian
author_facet Feng, Qiutian
Hu, Shiwei
Xiang, Danhong
Zhang, Xinlu
Zhang, Lan
Wang, Shengjie
Zhu, Xiaoqiong
Huang, Jian
author_sort Feng, Qiutian
collection PubMed
description
format Online
Article
Text
id pubmed-10431309
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104313092023-08-17 P1010: PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS HAVE INCREASED NUMBERS OF MYELOID-DERIVED SUPPRESSOR CELLS, AND DECITABINE MAY HAVE A SIGNIFICANT THERAPEUTIC EFFECT IN MPN PATIENTS WITH HIGH MDSCS Feng, Qiutian Hu, Shiwei Xiang, Danhong Zhang, Xinlu Zhang, Lan Wang, Shengjie Zhu, Xiaoqiong Huang, Jian Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431309/ http://dx.doi.org/10.1097/01.HS9.0000970944.20308.82 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Feng, Qiutian
Hu, Shiwei
Xiang, Danhong
Zhang, Xinlu
Zhang, Lan
Wang, Shengjie
Zhu, Xiaoqiong
Huang, Jian
P1010: PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS HAVE INCREASED NUMBERS OF MYELOID-DERIVED SUPPRESSOR CELLS, AND DECITABINE MAY HAVE A SIGNIFICANT THERAPEUTIC EFFECT IN MPN PATIENTS WITH HIGH MDSCS
title P1010: PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS HAVE INCREASED NUMBERS OF MYELOID-DERIVED SUPPRESSOR CELLS, AND DECITABINE MAY HAVE A SIGNIFICANT THERAPEUTIC EFFECT IN MPN PATIENTS WITH HIGH MDSCS
title_full P1010: PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS HAVE INCREASED NUMBERS OF MYELOID-DERIVED SUPPRESSOR CELLS, AND DECITABINE MAY HAVE A SIGNIFICANT THERAPEUTIC EFFECT IN MPN PATIENTS WITH HIGH MDSCS
title_fullStr P1010: PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS HAVE INCREASED NUMBERS OF MYELOID-DERIVED SUPPRESSOR CELLS, AND DECITABINE MAY HAVE A SIGNIFICANT THERAPEUTIC EFFECT IN MPN PATIENTS WITH HIGH MDSCS
title_full_unstemmed P1010: PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS HAVE INCREASED NUMBERS OF MYELOID-DERIVED SUPPRESSOR CELLS, AND DECITABINE MAY HAVE A SIGNIFICANT THERAPEUTIC EFFECT IN MPN PATIENTS WITH HIGH MDSCS
title_short P1010: PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS HAVE INCREASED NUMBERS OF MYELOID-DERIVED SUPPRESSOR CELLS, AND DECITABINE MAY HAVE A SIGNIFICANT THERAPEUTIC EFFECT IN MPN PATIENTS WITH HIGH MDSCS
title_sort p1010: patients with myeloproliferative neoplasms have increased numbers of myeloid-derived suppressor cells, and decitabine may have a significant therapeutic effect in mpn patients with high mdscs
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431309/
http://dx.doi.org/10.1097/01.HS9.0000970944.20308.82
work_keys_str_mv AT fengqiutian p1010patientswithmyeloproliferativeneoplasmshaveincreasednumbersofmyeloidderivedsuppressorcellsanddecitabinemayhaveasignificanttherapeuticeffectinmpnpatientswithhighmdscs
AT hushiwei p1010patientswithmyeloproliferativeneoplasmshaveincreasednumbersofmyeloidderivedsuppressorcellsanddecitabinemayhaveasignificanttherapeuticeffectinmpnpatientswithhighmdscs
AT xiangdanhong p1010patientswithmyeloproliferativeneoplasmshaveincreasednumbersofmyeloidderivedsuppressorcellsanddecitabinemayhaveasignificanttherapeuticeffectinmpnpatientswithhighmdscs
AT zhangxinlu p1010patientswithmyeloproliferativeneoplasmshaveincreasednumbersofmyeloidderivedsuppressorcellsanddecitabinemayhaveasignificanttherapeuticeffectinmpnpatientswithhighmdscs
AT zhanglan p1010patientswithmyeloproliferativeneoplasmshaveincreasednumbersofmyeloidderivedsuppressorcellsanddecitabinemayhaveasignificanttherapeuticeffectinmpnpatientswithhighmdscs
AT wangshengjie p1010patientswithmyeloproliferativeneoplasmshaveincreasednumbersofmyeloidderivedsuppressorcellsanddecitabinemayhaveasignificanttherapeuticeffectinmpnpatientswithhighmdscs
AT zhuxiaoqiong p1010patientswithmyeloproliferativeneoplasmshaveincreasednumbersofmyeloidderivedsuppressorcellsanddecitabinemayhaveasignificanttherapeuticeffectinmpnpatientswithhighmdscs
AT huangjian p1010patientswithmyeloproliferativeneoplasmshaveincreasednumbersofmyeloidderivedsuppressorcellsanddecitabinemayhaveasignificanttherapeuticeffectinmpnpatientswithhighmdscs